Cart
sales@molnova.com
HA-1004
CAS No. 91742-10-8
HA-1004( —— )
Catalog No. M27881 CAS No. 91742-10-8
HA-1004 is a inhibitor of PKG, PKA, PKC and MLC.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 393 | Get Quote |
|
| 10MG | 581 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1242 | Get Quote |
|
| 100MG | 1674 | Get Quote |
|
| 500MG | 3348 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHA-1004
-
NoteResearch use only, not for human use.
-
Brief DescriptionHA-1004 is a inhibitor of PKG, PKA, PKC and MLC.
-
DescriptionHA-1004 is a inhibitor of PKG, PKA, PKC and MLC.(In Vitro):HA-100 inhibits MLC-kinase and PKC competitively with respect to ATP, with Kis of 61 and 6.5 μM, respectively .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetSerine/threonin kinase
-
RecptorSurvivin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number91742-10-8
-
Formula Weight366.26
-
Molecular FormulaC12H17Cl2N5O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cl.NC(=N)NCCNS(=O)(=O)c1cccc2cnccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shi X, et al. GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells. Cancer Biol Ther. 2010 Apr 15;9(8):640-50.
molnova catalog
related products
-
kb-NB77-78
kb-NB77-78 is an analog of CID797718, which is a by-product of the synthesis of the parental compound, CID755673(PKD1 inhibitor).
-
Chymotrypsin
Chymotrypsin (Chymotrypsin A) is a serine protease synthesized by the pancreas, which cleaves protein chains on the carboxyl side of aromatic amino acids.
-
N-Cyclohexyl-4-[1-(1...
N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine is a novel 2,6-naphthyridine identified by high throughput screen (HTS) as a dual protein kinase C/D (PKC/PKD) inhibitor.
